NO20054852D0 - GFAT inhibitorer - Google Patents
GFAT inhibitorerInfo
- Publication number
- NO20054852D0 NO20054852D0 NO20054852A NO20054852A NO20054852D0 NO 20054852 D0 NO20054852 D0 NO 20054852D0 NO 20054852 A NO20054852 A NO 20054852A NO 20054852 A NO20054852 A NO 20054852A NO 20054852 D0 NO20054852 D0 NO 20054852D0
- Authority
- NO
- Norway
- Prior art keywords
- gfat inhibitors
- gfat
- inhibitors
- Prior art date
Links
- 101710185468 Glutamine-fructose-6-phosphate aminotransferase [isomerizing] Proteins 0.000 title 1
- 102100033429 Glutamine-fructose-6-phosphate aminotransferase [isomerizing] 1 Human genes 0.000 title 1
- 101710176049 Probable glutamine-fructose-6-phosphate aminotransferase [isomerizing] Proteins 0.000 title 1
- 101710198235 Putative glutamine-fructose-6-phosphate aminotransferase [isomerizing] Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47169003P | 2003-05-19 | 2003-05-19 | |
| PCT/EP2004/005025 WO2004101528A2 (en) | 2003-05-19 | 2004-05-11 | Isoquinoline derivatives and their use as gfat inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20054852D0 true NO20054852D0 (no) | 2005-10-20 |
| NO20054852L NO20054852L (no) | 2005-12-13 |
Family
ID=33452454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20054852A NO20054852L (no) | 2003-05-19 | 2005-10-20 | GFAT inhibitorer |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7067529B2 (no) |
| EP (1) | EP1631551A2 (no) |
| JP (1) | JP2006528218A (no) |
| KR (1) | KR100785571B1 (no) |
| CN (1) | CN100540537C (no) |
| AR (1) | AR044371A1 (no) |
| AU (1) | AU2004238521B2 (no) |
| BR (1) | BRPI0410760A (no) |
| CA (1) | CA2524958A1 (no) |
| CL (1) | CL2004001069A1 (no) |
| CO (1) | CO5630035A2 (no) |
| MX (1) | MXPA05012415A (no) |
| MY (1) | MY142768A (no) |
| NO (1) | NO20054852L (no) |
| NZ (1) | NZ543065A (no) |
| RU (1) | RU2320648C2 (no) |
| TW (1) | TW200426144A (no) |
| WO (1) | WO2004101528A2 (no) |
| ZA (1) | ZA200509290B (no) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007120638A2 (en) * | 2006-04-12 | 2007-10-25 | President And Fellows Of Harvard College | Methods and compositions for modulating glycosylation |
| AU2007283113A1 (en) | 2006-08-08 | 2008-02-14 | Sanofi-Aventis | Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use |
| DE102007005045B4 (de) | 2007-01-26 | 2008-12-18 | Sanofi-Aventis | Phenothiazin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| WO2008156676A1 (en) | 2007-06-15 | 2008-12-24 | President And Fellows Of Harvard College | Methods and compositions for detecting and modulating o-glycosylation |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| EP2085397A1 (en) * | 2008-01-21 | 2009-08-05 | Esteve Quimica, S.A. | Crystalline form of abacavir |
| CN101959495A (zh) * | 2008-02-29 | 2011-01-26 | 宝洁公司 | 毛发护理组合物和增加毛发直径的方法 |
| EP2310372B1 (en) | 2008-07-09 | 2012-05-23 | Sanofi | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| WO2010074244A1 (ja) * | 2008-12-25 | 2010-07-01 | 大正製薬株式会社 | イソキノリン誘導体 |
| JP2012528858A (ja) | 2009-06-01 | 2012-11-15 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | Ｏ−ＧｌｃＮＡｃ転移酵素阻害剤およびその使用 |
| JP2013503135A (ja) | 2009-08-26 | 2013-01-31 | サノフイ | 新規な結晶性複素芳香族フルオログリコシド水和物、その化合物を含んでなる医薬及びその使用 |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| JPWO2011162274A1 (ja) * | 2010-06-23 | 2013-08-22 | 大正製薬株式会社 | イソキノリン誘導体 |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8809324B2 (en) | 2011-03-08 | 2014-08-19 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| EP2683701B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120051A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| WO2012120057A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2013006758A1 (en) | 2011-07-06 | 2013-01-10 | President And Fellows Of Harvard College | Diphosphate mimetics and uses thereof |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2996775A1 (en) | 2013-05-16 | 2016-03-23 | The Procter & Gamble Company | Hair thickening compositions and methods of use |
| CN109456268A (zh) * | 2018-11-08 | 2019-03-12 | 中国药科大学 | C1位取代的3，4－二氢异喹啉类生物碱的制备及其医药用途 |
| CN110642854A (zh) * | 2019-11-20 | 2020-01-03 | 成都克莱蒙医药科技有限公司 | 一种稠环化合物的多晶型、其组合物、制备方法及其应用 |
| TW202214585A (zh) * | 2020-06-08 | 2022-04-16 | 加拿大商愛彼特生物製藥公司 | 經取代之異喹啉基甲基醯胺類、其類似物及使用其之方法 |
| WO2022150962A1 (en) * | 2021-01-12 | 2022-07-21 | Westlake Pharmaceutical (Hangzhou) Co., Ltd. | Protease inhibitors, preparation, and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2199462A1 (en) | 1972-09-21 | 1974-04-12 | Bruneau & Cie Lab | Papaveraldime oxime ethers and esters - analgesics and antiinflammatories prepd by treatment of papaveraldime oxime with an alkyl or acyl halide |
| GB1407685A (en) * | 1972-10-19 | 1975-09-24 | Allen & Hanburys Ltd | Isoquinolinium compounds |
| US4042697A (en) | 1972-10-19 | 1977-08-16 | Allen & Hanburys Limited | Isoquinolium compounds for treating diabetes |
| JPS63310813A (ja) | 1987-06-12 | 1988-12-19 | Keikichi Sugiyama | 毛髪用組成物 |
| GB9322828D0 (en) * | 1993-11-05 | 1993-12-22 | Sandoz Ltd | Organic compounds |
| US6400710B1 (en) * | 1999-07-09 | 2002-06-04 | Enron Warspeed Services, Inc. | Network with hot button for providing switched broadband multipoint/multimedia intercommunication |
| ES2172376B1 (es) | 2000-01-28 | 2003-11-16 | Servier Lab | Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
-
2004
- 2004-04-19 US US10/827,514 patent/US7067529B2/en not_active Expired - Fee Related
- 2004-05-11 BR BRPI0410760-8A patent/BRPI0410760A/pt not_active IP Right Cessation
- 2004-05-11 RU RU2005139524/04A patent/RU2320648C2/ru not_active IP Right Cessation
- 2004-05-11 JP JP2006529779A patent/JP2006528218A/ja active Pending
- 2004-05-11 CA CA002524958A patent/CA2524958A1/en not_active Abandoned
- 2004-05-11 AU AU2004238521A patent/AU2004238521B2/en not_active Ceased
- 2004-05-11 NZ NZ543065A patent/NZ543065A/en unknown
- 2004-05-11 WO PCT/EP2004/005025 patent/WO2004101528A2/en not_active Ceased
- 2004-05-11 MX MXPA05012415A patent/MXPA05012415A/es active IP Right Grant
- 2004-05-11 CN CNB2004800136909A patent/CN100540537C/zh not_active Expired - Fee Related
- 2004-05-11 EP EP04732111A patent/EP1631551A2/en not_active Withdrawn
- 2004-05-11 KR KR1020057021998A patent/KR100785571B1/ko not_active Expired - Fee Related
- 2004-05-14 TW TW093113583A patent/TW200426144A/zh unknown
- 2004-05-17 MY MYPI20041856A patent/MY142768A/en unknown
- 2004-05-17 AR ARP040101698A patent/AR044371A1/es unknown
- 2004-05-17 CL CL200401069A patent/CL2004001069A1/es unknown
-
2005
- 2005-10-20 NO NO20054852A patent/NO20054852L/no unknown
- 2005-11-16 ZA ZA200509290A patent/ZA200509290B/en unknown
- 2005-11-16 CO CO05116287A patent/CO5630035A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006528218A (ja) | 2006-12-14 |
| KR20060015267A (ko) | 2006-02-16 |
| CO5630035A2 (es) | 2006-04-28 |
| AU2004238521A1 (en) | 2004-11-25 |
| WO2004101528A2 (en) | 2004-11-25 |
| KR100785571B1 (ko) | 2007-12-13 |
| CA2524958A1 (en) | 2004-11-25 |
| EP1631551A2 (en) | 2006-03-08 |
| HK1091838A1 (zh) | 2007-01-26 |
| RU2320648C2 (ru) | 2008-03-27 |
| US7067529B2 (en) | 2006-06-27 |
| CN1791581A (zh) | 2006-06-21 |
| NO20054852L (no) | 2005-12-13 |
| RU2005139524A (ru) | 2007-06-27 |
| TW200426144A (en) | 2004-12-01 |
| CL2004001069A1 (es) | 2005-04-01 |
| BRPI0410760A (pt) | 2006-06-27 |
| WO2004101528A3 (en) | 2005-01-06 |
| CN100540537C (zh) | 2009-09-16 |
| US20040259910A1 (en) | 2004-12-23 |
| NZ543065A (en) | 2009-07-31 |
| MY142768A (en) | 2010-12-31 |
| MXPA05012415A (es) | 2006-02-13 |
| AR044371A1 (es) | 2005-09-07 |
| AU2004238521B2 (en) | 2007-07-26 |
| ZA200509290B (en) | 2007-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054852D0 (no) | GFAT inhibitorer | |
| DE602004018837D1 (de) | Ptidase-iv-inhibitoren | |
| EP1737811A4 (en) | CETP INHIBITORS | |
| DE60320933D1 (de) | Rho-kinase inhibitoren | |
| ATE363383T1 (de) | Schlingenware | |
| DE502004001683D1 (de) | Kabelführung | |
| DE60324208D1 (de) | Biarylsulfonamide als mmp-inhibitoren | |
| AT502792A5 (de) | Düsenanpressvorrichtung | |
| DE502004007911D1 (de) | Wischblatt | |
| DE112004000620D2 (de) | Struktoguss | |
| ATE545642T1 (de) | Mmp-inhibitoren | |
| DE502004000672D1 (de) | Pigmentpreparationen | |
| DE10355350A8 (de) | Elektromodul | |
| DE502004001524D1 (de) | Hydrolager | |
| ATA662003A (de) | Trink-mundstück | |
| ATE446959T1 (de) | Chromenonindole | |
| DE502004001629D1 (de) | Bremsenprüfstand | |
| DE502004002978D1 (de) | N-biarylamide | |
| DE502004003122D1 (de) | Hydrolager | |
| DE502004005162D1 (de) | Leistungsregelvorricthung | |
| DE112004002227D2 (de) | Nietverarbeitungsgerät | |
| DE502004006563D1 (de) | Brieftaubenkonstatiersystem | |
| DE502004000518D1 (de) | Mitgängergabelhubwagen | |
| DE10394329D2 (de) | Mäanderstent | |
| DE10329218B4 (de) | Hotflue |